Literature DB >> 23707282

Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.

Pierre-Eric Juif1, Pierrick Poisbeau.   

Abstract

Oxytocin (OT) and arginine vasopressin (AVP) are 2 neuropeptides that display well-known effects on the reproductive system. Although still controversial, oxytocin and vasopressin were demonstrated to exert potent effects on the nociceptive system when administered directly in various central nervous structures. On the other hand, little is known about their peripheral (hormonal) actions on nociception and pain responses. The aim of the present work was to characterize the effects of physiological blood concentrations of OT and AVP on spinal nociception and on pain responses. To do so, growing doses of OT or AVP were administered intravenously and the nociceptive processing by spinal cord neurons was analyzed in anesthetized male rats in vivo. We observed that the action potentials mediated by C-type nociceptive fibers was strongly reduced (antinociception) after intravenous injections of low doses of OT (<5 μg) or AVP (<500 pg), whereas an increase (pronociception) was observed at higher doses. Interestingly, antinociceptive and pronociceptive effects were fully abolished in the presence of the OT receptor antagonist and the AVP receptor antagonist type 1A (V1A), respectively. We confirmed this result with a behavioral model of forced swim stress-induced analgesia associated with plasmatic release of OT (and not vasopressin). Stress-induced analgesia was transiently lost after i.v. administration of OTR antagonist. Together, the present work provides straightforward evidence that blood levels of OT and AVP modulate nociception, windup plasticity and pain responses. The final target structures explaining these effects remains to be identified but are likely to be C-type nociceptors.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707282     DOI: 10.1016/j.pain.2013.05.003

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  19 in total

Review 1.  Oxytocin - a multifunctional analgesic for chronic deep tissue pain.

Authors:  Burel R Goodin; Timothy J Ness; Meredith T Robbins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP.

Authors:  Diana N Krause; Karin Warfvinge; Kristian Agmund Haanes; Lars Edvinsson
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

3.  Oxytocin Modulates Nociception as an Agonist of Pain-Sensing TRPV1.

Authors:  Yelena Nersesyan; Lusine Demirkhanyan; Deny Cabezas-Bratesco; Victoria Oakes; Ricardo Kusuda; Tyler Dawson; Xiaohui Sun; Chike Cao; Alejandro Martin Cohen; Bharath Chelluboina; Krishna Kumar Veeravalli; Katharina Zimmermann; Carmen Domene; Sebastian Brauchi; Eleonora Zakharian
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

4.  A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing.

Authors:  Marina Eliava; Meggane Melchior; H Sophie Knobloch-Bollmann; Jérôme Wahis; Miriam da Silva Gouveia; Yan Tang; Alexandru Cristian Ciobanu; Rodrigo Triana Del Rio; Lena C Roth; Ferdinand Althammer; Virginie Chavant; Yannick Goumon; Tim Gruber; Nathalie Petit-Demoulière; Marta Busnelli; Bice Chini; Linette L Tan; Mariela Mitre; Robert C Froemke; Moses V Chao; Günter Giese; Rolf Sprengel; Rohini Kuner; Pierrick Poisbeau; Peter H Seeburg; Ron Stoop; Alexandre Charlet; Valery Grinevich
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

5.  Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons.

Authors:  Fang Qiu; Chun-Yu Qiu; Huilan Cai; Ting-Ting Liu; Zu-Wei Qu; Zhifan Yang; Jia-Da Li; Qun-Yong Zhou; Wang-Ping Hu
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model.

Authors:  Abimael González-Hernández; Antonio Espinosa De Los Monteros-Zuñiga; Guadalupe Martínez-Lorenzana; Miguel Condés-Lara
Journal:  Exp Brain Res       Date:  2019-09-12       Impact factor: 1.972

7.  Oxytocin Receptor Activation Rescues Opioid-Induced Respiratory Depression by Systemic Fentanyl in the Rat.

Authors:  Allison Doyle Brackley; Glenn M Toney
Journal:  J Pharmacol Exp Ther       Date:  2021-05-14       Impact factor: 4.402

8.  Plasticity and Function of Spinal Oxytocin and Vasopressin Signaling during Recovery from Surgery with Nerve Injury.

Authors:  Amie L Severino; Rong Chen; Kenichiro Hayashida; Carol A Aschenbrenner; Haiguo Sun; Christopher M Peters; Silvia Gutierrez; Bethany Pan; James C Eisenach
Journal:  Anesthesiology       Date:  2018-09       Impact factor: 8.986

9.  Oxytocin inhibits hindpaw hyperalgesia induced by orofacial inflammation combined with stress.

Authors:  Yue-Xin Li; Jia-Heng Li; Yi Guo; Zhuo-Ying Tao; Shi-Hao Qin; Richard J Traub; Hong An; Dong-Yuan Cao
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.370

Review 10.  Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part II).

Authors:  Fuzhou Wang; George B Stefano; Richard M Kream
Journal:  Med Sci Monit       Date:  2014-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.